Mo, Jing https://orcid.org/0000-0002-5341-2995
Chen, Zonggui https://orcid.org/0000-0003-3346-2765
Cui, Manman
Fang, Xin
Li, Ruihan
Qin, Shanshan
Zhou, Zhenlin
Sun, Mei
Wu, Jinjun https://orcid.org/0000-0002-2379-1162
He, Chuan https://orcid.org/0000-0003-4319-7424
Wang, Fang
Zhang, Haojian https://orcid.org/0000-0002-9394-9383
Zhou, Xiang https://orcid.org/0000-0002-1829-9368
Weng, Xiaocheng https://orcid.org/0000-0002-0605-8495
Article History
Received: 31 July 2023
Accepted: 11 July 2025
First Online: 7 August 2025
Change Date: 25 August 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41589-025-02028-6
Competing interests
: C.H. is a scientific founder, member of the scientific advisory board and equity holder of Aferna Bio and Ellis Bio, a scientific cofounder and equity holder of Accent Therapeutics and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The other authors declare no competing interests.